Menopausal hormonal therapy and contraception for female with diabetes mellitus. Modern positions according to standards of specialized diabetes care (12[th] edition)
https://doi.org/10.14341/brh12802
Abstract
The present article contains the most actual (according to year 2026) information about initiation, providing and efficacy control of menopausal hormonal therapy and contraception among females with diabetes mellitus. The present data have been collected and presented according to results of completed mecical researches, actual international and Russian national recommendations for treament of diabetes mellitus type 1 and 2, many years of comorbity treatment experience in the Endocrinology Research Centre (Moscow, Russia)
About the Authors
E. N. Andreeva
Endocrinology Research Centre; Russian University of Medicine
Russian Federation
Competing Interests:
Russian Federation
Elena N. Andreeva, MD, PhD, Professor
Dm. Ulyanova street, 117036, Moscow
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.
O. R. Grigoryan
Endocrinology Research Centre
Russian Federation
Competing Interests:
Russian Federation
Olga R. Grigoryan, MD, Doctor of Sciences, professor
Dm. Ulyanova street, 117036, Moscow
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.
References
1. Клинические рекомендации «Менопауза и климактерическое состояние у женщины», 2025. ID_841_1. _https://cr.minzdrav.gov.ru/preview-cr/117-3
2. Sukhikh G.T., Serov V.N., Shlyakhto E.V., Dedov I.I., et al.. Menopausal hormone therapy in patients with cardiovascular and metabolic diseases: an interdisciplinary Delphi consensus among Russian gynecologists, cardiologists, endocrinologists, gerontologists and geriatricians, phlebologists, and clinical pharmacologists // Terapevticheskii arkhiv. - 2026. - Vol. 98. - N. 1. - P. 6-27. doi: https://doi.org/10.26442/00403660.2026.01.203470
3. Zhang K, Ma Y, Luo Y, et al. Metabolic diseases and healthy aging: identifying environmental and behavioral risk factors and promoting public health. Front Public Health. 2023;11:1253506. doi: https://doi.org/10.3389/fpubh.2023.1253506
4. Panay N, Ang SB, Cheshire R, et al. Menopause and MHT in 2024: addressing the key controversies – an International Menopause Society White Paper. Climacteric. 2024;27(5):441-57. doi: https://doi.org/10.1080/13697137.2024.2394950
5. Шляхто Е.В., Сухих Г.Т., Серов В.Н., Дедов И.И., и соавт. Российские критерии приемлемости назначения менопаузальной гормональной терапии пациенткам с сердечно-сосудистыми и метаболическими заболеваниями. Согласительный документ РКО, РОАГ, РАЭ, ЕАТ, РАФ. Проблемы Эндокринологии. 2023;69(5):115-136. https://doi.org/10.14341/probl13394
6. Клинические рекомендации «Контрацепция. Наблюдение за применением противозачаточных средств» (проект), 2024. https:// drive.google.com/file/d/17x4DcHeYuYy9qS7zzXvMzyV5MkIC1tvN/view
7. Panou T, Gouveri E, Gerede A, Tsikouras P, Papazoglou D, Papanas N. Contraception and Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2025;133(5):268-277. doi: 10.1055/a-2561-9460
8. Abushamat LA, Sayres L, Jeffers R, Nielsen C, Barbour LA, Zaman A. Unmasking Barriers in the Delivery of Preconception Counseling and Contraception Provision for Patients With Type 1 or Type 2 Diabetes. Clin Diabetes. 2023;41(4):567-572. doi: https://doi.org/10.2337/cd23-0008
Review
For citations:
Andreeva E.N., Grigoryan O.R. Menopausal hormonal therapy and contraception for female with diabetes mellitus. Modern positions according to standards of specialized diabetes care (12[th] edition). Bulletin of Reproductive Health. 2026;5(2):53-60. (In Russ.) https://doi.org/10.14341/brh12802
Views:
14
JATS XML
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
